ARKG vs AVUV
ARK Genomic Revolution ETF vs Avantis US Small Cap Value ETF
ARKG$43.00
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: 0.75%Yield: 0.00%
AVUV$123.22
Avantis US Small Cap Value ETF
US small-cap value with profitability screen.
Expense: 0.25%Yield: 1.25%
Quick take
- • AVUV has the lower expense ratio at 0.25% vs 0.75% for ARKG.
- • AVUV pays a higher dividend yield (1.25%).
Side-by-side metrics
| Metric | ARKG | AVUV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.25% |
Dividend yield Trailing 12-month yield. | 0.00% | 1.25% |
AUM Assets under management — bigger funds are typically more liquid. | $1.73B | $29.06B |
YTD return | 44.53% | 20.76% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.38 | 0.98 |
P/E ratio | — | 13.54 |
Last price | $43.00 | $123.22 |
Inception | — | — |
Issuer | ARK | Avantis |
ARKG top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 9.15% |
| TEM | Tempus AI Inc Class A common stock | 7.64% |
| ABSI | Absci Corp | 7.01% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 7.00% |
| CRSP | CRISPR Therapeutics AG | 6.56% |
| PSNL | Personalis Inc | 6.19% |
| BEAM | Beam Therapeutics Inc | 4.34% |
| GH | Guardant Health Inc | 4.28% |
| NTRA | Natera Inc | 4.11% |
| ILMN | Illumina Inc | 3.98% |
Sector breakdown · ARKG
Healthcare100.0%
AVUV top holdings
Top holdings · AVUV
| VSAT | Viasat Inc | 1.39% |
| MATX | Matson Inc | 1.02% |
| LNTH | Lantheus Holdings Inc | 0.86% |
| IRDM | Iridium Communications Inc | 0.78% |
| AVT | Avnet Inc | 0.78% |
| M | Macy's Inc | 0.76% |
| LEA | Lear Corp | 0.75% |
| GATX | GATX Corp | 0.74% |
| AROC | Archrock Inc | 0.73% |
| CBT | Cabot Corp | 0.73% |
Sector breakdown · AVUV
Real Estate0.7%
Consumer Cyclical18.5%
Basic Materials4.8%
Consumer Defensive4.9%
Technology7.4%
Communication Services2.9%
Financial Services27.8%
Utilities0.2%
Industrials13.5%
Energy13.9%
Healthcare5.3%
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.7B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 9.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About AVUV
AVUV (Avantis US Small Cap Value ETF) is US small-cap value with profitability screen. Managed by Avantis, the fund carries $29.1B in assets under management, an expense ratio of 0.25%, a dividend yield of 1.25%. Its largest holding is Viasat Inc (VSAT), which represents 1.4% of the portfolio. Real Estate is the fund's largest sector exposure at 0.7%.